HERVolution Therapeutics

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$11.7M

HERVolution Therapeutics is a biotechnology company developing immunotherapy treatments targeting human endogenous retroviruses for cancer and aging-related diseases.